Novo Nordisk submits sNDA to FDA for for higher semaglutide injection dose

Vascular Perfusion Solutions forms collaboration to advance biostasis compounds for organ preservation

SK Biopharmaceuticals signs licence agreement with Wisconsin Alumni Research Foundation

BeOne Medicines' sonrotoclax granted FDA Priority Review for relapsed or refractory mantle cell lymphoma

Valneva reports positive final Phase 2 results for Lyme disease vaccine VLA15

AstraZeneca wins US approval for Imfinzi as first perioperative immunotherapy in early gastric and GEJ cancer

Curasight begins phase 1 trial of uTREAT in glioblastoma

Lunai Bioworks receives first LOI to license next-generation immune cell therapy

Novo Nordisk reports strong phase 2 results for amycretin in type 2 diabetes

Active Biotech to receive US patent for tasquinimod formulation

Sanofi and Regeneron's Dupixent approved in EU for chronic spontaneous urticaria

Clearmind Medicine advances global CMND-100 AUD trial with first patient enrolled in Israel

NeuroSense's PrimeC receives FDA clearance for pivotal Phase 3 trial in ALS

Made Scientific enters manufacturing partnership with Cellergy Therapeutics

Novartis' Itvisma granted US FDA approval for spinal muscular atrophy treatment